Teva Pharmaceutical Industries €2 billion eurobond issue

Overview:

• Teva Pharmaceutical Industries has issued €2 billion in notes.
• The notes were offered in two series - €1.3 billion 1.25% notes due March, 2023, and €700 billion 1.875% notes due March, 2027.
• The offering was made through Teva Pharmaceutical Finance Netherlands.
• The underwriters were led by Barclays, BNP Paribas, HSBC and Morgan Stanley.
• The issue is only the second Eurobond ever issued by Teva.

Kurt Stumpo - Journalist